Earlier this week, Tweed Marijuana Inc. (TWD) completed the acquisition of Bedrocan Cannabis Corp. (BED). The acquisition successfully combined the two largest Canadian medical marijuana producers and created a conglomerate in the Canadian medical marijuana industry.
The first priority for the newly combined company is to integrate its more than 5,600 active and registered clients and build on the unique strengths of each brand. Starting tomorrow, patients will have access to both product lines.
Strategic acquisition will help with client integration
Today, Tweed entered into an agreement to acquire MedCannAccess in an all-equity transaction. Tweed will be able to offer in-person client services through MedCannAccess’s network of community engagement centers in Ontario. This acquisition makes Tweed the first licensed producer in Canada to offer in-person services.
Under the agreement, Tweed acquired a 33% stake in CannScience Innovations Inc., a drug development company based out of Toronto. CannScience conducts extracts research and is focused on delivering standardized metered dosing in a range of alternate delivery methods.
Tweed also acquired a library of proprietary genetics produced by Humber Valley Seeds. This will further diversify the company’s product offerings and create opportunities for breeding and product development.
Bedrocan and Tweed continue to receive license approvals
On August 27th, Bedrocan received a license amendment from Health Canada that allows them to sell up to 2,000 kilograms of medical marijuana until February 17, 2016. The company also retained its license to sell up to 240 kilograms from its second facility.
The increased capacity came a few days after Bedrocan’s production facility was fully licensed by Health Canada. These license amendments significantly expand the company’s production capacity and reach.
In mid-August, Tweed received approval from Health Canada to begin the production of cannabis extracts in its facility in Smiths Falls, Ontario. Health Canada also approved seven climate-controlled drying rooms, a trimming room, an extraction room and a processing room.
This has been a big week for the Canadian medical marijuana industry and we are favorable on TWD at current levels. Tweed and Bedrocan will continue to grab market share in a rapidly growing industry that is in its infancy. We expect to see incremental revenue growth quarter-over-quarter.
Authored by: Michael Berger
Michael Berger is the president and founder of Technical420, an independent research firm focused specifically on the cannabis sector. He was working for the equity research department at Raymond James Financial Inc., when he recognized a need for a service that provides up-to-date research and analysis on companies that operate in the cannabis industry. Mr. Berger studied finance and economics at Florida State University and is working toward achieving his CFA charter.
Technical 420 LLC
MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | firstname.lastname@example.org